Stéphane Bancel (AP Images, Boston Herald)
January 7, 2022 07:21 AM ESTUpdated 11:01 AM
Coronavirus

Covid-19 roundup: FDA short­ens in­ter­val for Mod­er­na boost­er dose to 5 months; Mod­er­na CEO says an­oth­er boost­er could be nec­es­sary this fall — re­port

Nicole DeFeudis

Editor

The FDA has short­ened the rec­om­mend­ed in­ter­val be­tween the pri­ma­ry se­ries of Mod­er­na’s Covid-19 vac­cine and a boost­er shot to at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times